Võrdle meetodeid

	Molekulaarne dokkimine	Homoloogia modelleerimine	Farmakofoorimudelite loomine
Valdkond	Bioinformaatika	Bioinformaatika	Bioinformaatika
Perekond	Process / pipeline	Process / pipeline	Process / pipeline
Tekkeaasta	1982	1993	1977
Looja	Irwin Kuntz	Andrej Sali	Peter Gund
Tüüp	Binding prediction pipeline	Comparative structure prediction pipeline	Pattern-based virtual screening pipeline
Algallikas	Kuntz, I. D., Blaney, J. M., Oatley, S. J., Langridge, R., & Ferrin, T. E. (1982). A geometric approach to macromolecule-ligand interactions. Journal of Molecular Biology, 161(2), 269-288.	Sali, A. & Blundell, T. L. (1993). Comparative protein modelling by satisfaction of spatial restraints. Journal of Molecular Biology, 234(3), 779-815.	Wermuth, C. G., Ganellin, C. R., Lindberg, P., & Mitscher, L. A. (1998). Glossary of terms used in medicinal chemistry. Pure and Applied Chemistry, 70(5), 1129-1143.
Rööpnimetused	protein-ligand docking, binding prediction	comparative modeling, template-based modeling	pharmacophore pattern recognition, 3D pharmacophore
Seotud	4	4	3
Kokkuvõte	Molecular docking predicts the preferred binding orientation and affinity of a ligand (small molecule) within a protein binding pocket. Pioneered by Kuntz and colleagues in 1982, this computational method searches conformational space to find energetically favorable ligand-protein complexes, enabling rapid screening of chemical libraries for drug discovery.	Homology modeling, also called comparative modeling, predicts the three-dimensional structure of a protein using an experimentally-solved structure of a homologous protein as a template. Introduced by Sali and Blundell in 1993, this method exploits the principle that homologous proteins share similar spatial structures despite differing in amino acid sequence.	Pharmacophore modeling identifies the spatial arrangement of molecular features (hydrogen bond donors, acceptors, aromatic rings) that are essential for biological activity. Introduced by Gund in 1977, this ligand-based method creates a three-dimensional pattern that can screen chemical libraries and design new active compounds without requiring receptor structure.